Financials data is unavailable for this security.
Cash flow in USDView more
In 2024, Propanc Biopharma Inc increased its cash reserves by 109.85%, or 11.04k. Cash Flow from Financing totalled 941.89k or -- of revenues. In addition the company used 935.12k for operations while cash used for investing totalled .
Cash flow per share | -0.008 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.006 |
---|---|
Tangible book value per share | -0.006 |
More ▼
Balance sheet in USDView more
Current ratio | 0.0053 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼